Trial · NCT07911410
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Toronto Clinical Scoring System (TCSS) total score from baseline to 3 months after surgery | 3 months after surgery | Change in total score of the Toronto Clinical Scoring System (TCSS) measured at 3 months after surgery relative to baseline. Full scale name: Toronto Clinical Scoring System Scale range: Minimum score = 0, Maximum score = 19 Interpretation: Higher total score indicates more severe diabetic peripheral neuropathy. Lower total score indicates less severe neuropathy. |
| Secondary | Plantar Temperature | Postoperative day 1 | Bilateral plantar temperature measured before PNS activation on postoperative day 1. |
| Secondary | Percentage Change in Neuropathic Symptom Score at Postoperative Day 1 | Postoperative day 1 | Percentage change in neuropathic symptom score assessed one day after surgery relative to baseline. |
| Secondary | Stable Minimum Bilateral Plantar Temperature After One-week PNS Stimulation | One week after PNS stimulation (before electrode removal) | The minimum stable bilateral plantar temperature recorded before electrode removal after one week of peripheral nerve stimulation. |
| Secondary | Percentage Change in Diabetic Neuropathic Symptom Score Before Electrode Removal | One week after PNS stimulation | Percentage change in diabetic neuropathic symptom score assessed before electrode removal after one week of continuous PNS stimulation, relative to baseline. |
| Secondary | Diabetic Foot Risk Status at 3 Months Postoperatively | 3 months after operation | Comprehensive assessment of diabetic foot risk indicators at 3 months after surgery. |
| Secondary | Change in Lower Limb Nerve Conduction Velocity Measured by Electromyography at 3 Months Postoperatively | 3 months after operation | Change in lower limb nerve conduction velocity detected by electromyography at 3 months after surgery. |
| Secondary | Status of Neurotrophic Agent Use at 3 Months Postoperatively | 3 months after operation | Changes in the use and dosage of neurotrophic drugs at 3 months after surgery. |
| Secondary | Status of Hypoglycemic Agent Use at 3 Months Postoperatively | 3 months after operation | Changes in the use and dosage of hypoglycemic agents at 3 months after surgery. |
| Secondary | Status of Analgesic Medication Use at 3 Months Postoperatively | 3 months after operation | Changes in the use and dosage of analgesic medications at 3 months after surgery. |
| Secondary | Participant-reported Satisfaction Level for Combined Surgical Treatment at 3 Months Postoperatively | 3 months after operation | Participant self-reported satisfaction level regarding the combined surgical treatment at 3 months after surgery. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07911410/registered